ReP USP - Resultado da busca

Artigo de periodico
SETDB1 as a cancer target: challenges and perspectives in drug design (2024)
Hassanie, Haifa ; Penteado, André Berndt ; Almeida, Larissa Costa de ; Calil, Raisa Ludmila; Emery, Flavio da Silva ; Costa-Lotufo, Letícia Veras ; Trossini, Gustavo Henrique Goulart
Fonte: RSC Medicinal Chemistry. Unidades: FCFRP, ICB, FCF
Assuntos: NEOPLASIAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HASSANIE, Haifa et al. SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, v. 15, n. 5, p. 1424-1451, 2024Tradução . . Disponível em: https://dx.doi.org/10.1039/D3MD00366C. Acesso em: 09 ago. 2024.
APA
Hassanie, H., Penteado, A. B., Almeida, L. C. de, Calil, R. L., Emery, F. da S., Costa-Lotufo, L. V., & Trossini, G. H. G. (2024). SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, 15( 5), 1424-1451. doi:10.1039/D3MD00366C
NLM
Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2024 ago. 09 ] Available from: https://dx.doi.org/10.1039/D3MD00366C
Vancouver
Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2024 ago. 09 ] Available from: https://dx.doi.org/10.1039/D3MD00366C
Curadoria
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11 (2023)
Andricopulo, Adriano Defini (cur) ; Trossini, Gustavo Henrique Goulart (cur) ; Nonato, Maria Cristina (cur) ; Nascimento, Alessandro Silva (cur) ; Emery, Flavio da Silva (cur) ; Dias, Marcio Vinicius Bertacine (cur) ; Parise Filho, Roberto (cur)
Unidades: IFSC, FCF, FCFRP, ICB
Assuntos: CRISTALOGRAFIA, QUÍMICA MÉDICA, PESQUISA CIENTÍFICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11. . Salvador: Universidade Federal da Bahia - UFBA. . Acesso em: 09 ago. 2024. , 2023
APA
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11. (2023). Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11. Salvador: Universidade Federal da Bahia - UFBA.
NLM
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11. 2023 ;[citado 2024 ago. 09 ]
Vancouver
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11. 2023 ;[citado 2024 ago. 09 ]
Artigo de periodico
Human sirtuin 2 inhibitors, their mechanisms and binding modes (2023)
Penteado, André Berndt ; Hassanie, Haifa ; Gomes, Renan Augusto ; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Fonte: Future Medicinal Chemistry. Unidades: FCFRP, FCF
Assuntos: METABOLISMO, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PENTEADO, André Berndt et al. Human sirtuin 2 inhibitors, their mechanisms and binding modes. Future Medicinal Chemistry, v. 15, n. 3, p. 291-311, 2023Tradução . . Disponível em: https://doi.org/10.4155/fmc-2022-0253. Acesso em: 09 ago. 2024.
APA
Penteado, A. B., Hassanie, H., Gomes, R. A., Emery, F. da S., & Trossini, G. H. G. (2023). Human sirtuin 2 inhibitors, their mechanisms and binding modes. Future Medicinal Chemistry, 15( 3), 291-311. doi:10.4155/fmc-2022-0253
NLM
Penteado AB, Hassanie H, Gomes RA, Emery F da S, Trossini GHG. Human sirtuin 2 inhibitors, their mechanisms and binding modes [Internet]. Future Medicinal Chemistry. 2023 ; 15( 3): 291-311.[citado 2024 ago. 09 ] Available from: https://doi.org/10.4155/fmc-2022-0253
Vancouver
Penteado AB, Hassanie H, Gomes RA, Emery F da S, Trossini GHG. Human sirtuin 2 inhibitors, their mechanisms and binding modes [Internet]. Future Medicinal Chemistry. 2023 ; 15( 3): 291-311.[citado 2024 ago. 09 ] Available from: https://doi.org/10.4155/fmc-2022-0253
Artigo de periodico
Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design (2023)
Ferreira, Glaucio Monteiro ; Kronenberger, Thales ; Maltarollo, Vinícius Gonçalves ; Poso, Antti ; Gatti, Fernando de Moura ; Almeida, Vitor Medeiros ; Marana, Sandro Roberto ; Lopes, Carla Duque ; Tezuka, Daiane Yukie; Albuquerque, Sérgio de ; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Fonte: Pharmaceuticals. Unidades: FCF, IQ, FCFRP
Assuntos: TRYPANOSOMA CRUZI, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Glaucio Monteiro et al. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design. Pharmaceuticals, v. 16 , p. 1-14 art. 428, 2023Tradução . . Disponível em: https://doi.org/10.3390/ph16030428. Acesso em: 09 ago. 2024.
APA
Ferreira, G. M., Kronenberger, T., Maltarollo, V. G., Poso, A., Gatti, F. de M., Almeida, V. M., et al. (2023). Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design. Pharmaceuticals, 16 , 1-14 art. 428. doi:10.3390/ph16030428
NLM
Ferreira GM, Kronenberger T, Maltarollo VG, Poso A, Gatti F de M, Almeida VM, Marana SR, Lopes CD, Tezuka DY, Albuquerque S de, Emery F da S, Trossini GHG. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design [Internet]. Pharmaceuticals. 2023 ; 16 1-14 art. 428.[citado 2024 ago. 09 ] Available from: https://doi.org/10.3390/ph16030428
Vancouver
Ferreira GM, Kronenberger T, Maltarollo VG, Poso A, Gatti F de M, Almeida VM, Marana SR, Lopes CD, Tezuka DY, Albuquerque S de, Emery F da S, Trossini GHG. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design [Internet]. Pharmaceuticals. 2023 ; 16 1-14 art. 428.[citado 2024 ago. 09 ] Available from: https://doi.org/10.3390/ph16030428
Artigo de periodico
Parasitic sirtuin 2 as an opportunity in drug discovery (2021)
Gomes, Renan Augusto ; Fornari, Evelin; Rocha, Ana Carolina Silva; Tripodi, Gustavo Luis; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Fonte: Future Medicinal Chemistry. Unidades: FCFRP, FCF
Assuntos: ANTIPROTOZOÁRIOS, EPIGÊNESE GENÉTICA, DOENÇAS INFECCIOSAS, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Renan Augusto et al. Parasitic sirtuin 2 as an opportunity in drug discovery. Future Medicinal Chemistry, v. 13, n. 16, p. 1397-1409, 2021Tradução . . Disponível em: https://doi.org/10.4155/fmc-2021-0091. Acesso em: 09 ago. 2024.
APA
Gomes, R. A., Fornari, E., Rocha, A. C. S., Tripodi, G. L., Emery, F. da S., & Trossini, G. H. G. (2021). Parasitic sirtuin 2 as an opportunity in drug discovery. Future Medicinal Chemistry, 13( 16), 1397-1409. doi:10.4155/fmc-2021-0091
NLM
Gomes RA, Fornari E, Rocha ACS, Tripodi GL, Emery F da S, Trossini GHG. Parasitic sirtuin 2 as an opportunity in drug discovery [Internet]. Future Medicinal Chemistry. 2021 ; 13( 16): 1397-1409.[citado 2024 ago. 09 ] Available from: https://doi.org/10.4155/fmc-2021-0091
Vancouver
Gomes RA, Fornari E, Rocha ACS, Tripodi GL, Emery F da S, Trossini GHG. Parasitic sirtuin 2 as an opportunity in drug discovery [Internet]. Future Medicinal Chemistry. 2021 ; 13( 16): 1397-1409.[citado 2024 ago. 09 ] Available from: https://doi.org/10.4155/fmc-2021-0091
Artigo de periodico
Insights into newly approved drugs from a medicinal chemistry perspective (2021)
Lima, Elys Juliane Cardoso ; Gomes, Renan Augusto ; Fornari, Evelin; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Fonte: Mini-Reviews in Medicinal Chemistry. Unidades: FCFRP, FCF
Assunto: FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Elys Juliane Cardoso et al. Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, v. 21, n. 16, p. 2227-2248, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389557521666210226145328. Acesso em: 09 ago. 2024.
APA
Lima, E. J. C., Gomes, R. A., Fornari, E., Emery, F. da S., & Trossini, G. H. G. (2021). Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, 21( 16), 2227-2248. doi:10.2174/1389557521666210226145328
NLM
Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 ago. 09 ] Available from: https://doi.org/10.2174/1389557521666210226145328
Vancouver
Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 ago. 09 ] Available from: https://doi.org/10.2174/1389557521666210226145328
Artigo de periodico
QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives (2020)
Ferreira, Glaucio Monteiro; Magalhães, Juliana Gallottini de; Maltarollo, Vinícius Gonçalves; Kronenberger, Thales; Ganesan, Arasu; Emery, Flavio da Silva; Trossini, Gustavo Henrique Goulart
Fonte: Journal of Biomolecular Structure and Dynamics. Unidades: FCFRP, FCF
Assuntos: RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA, EPIGÊNESE GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Glaucio Monteiro et al. QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives. Journal of Biomolecular Structure and Dynamics, v. 38, n. 2, p. 354-363, 2020Tradução . . Disponível em: https://doi.org/10.1080/07391102.2019.1574603. Acesso em: 09 ago. 2024.
APA
Ferreira, G. M., Magalhães, J. G. de, Maltarollo, V. G., Kronenberger, T., Ganesan, A., Emery, F. da S., & Trossini, G. H. G. (2020). QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives. Journal of Biomolecular Structure and Dynamics, 38( 2), 354-363. doi:10.1080/07391102.2019.1574603
NLM
Ferreira GM, Magalhães JG de, Maltarollo VG, Kronenberger T, Ganesan A, Emery F da S, Trossini GHG. QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives [Internet]. Journal of Biomolecular Structure and Dynamics. 2020 ; 38( 2): 354-363.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1080/07391102.2019.1574603
Vancouver
Ferreira GM, Magalhães JG de, Maltarollo VG, Kronenberger T, Ganesan A, Emery F da S, Trossini GHG. QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives [Internet]. Journal of Biomolecular Structure and Dynamics. 2020 ; 38( 2): 354-363.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1080/07391102.2019.1574603
Curadoria
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 9 (2019)
Andricopulo, Adriano Defini (cur) ; Amaral, Antonia Tavares do (cur) ; Ferreira, Elizabeth Igne (cur) ; Emery, Flavio da Silva (cur) ; Trossini, Gustavo Henrique Goulart (cur)
Unidades: IFSC, IQ, FCF, FCFRP
Assuntos: QUÍMICA, PESQUISA CIENTÍFICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 9. . São Paulo: Sociedade Brasileira de Química - SBQ. . Acesso em: 09 ago. 2024. , 2019
APA
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 9. (2019). Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 9. São Paulo: Sociedade Brasileira de Química - SBQ.
NLM
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 9. 2019 ;[citado 2024 ago. 09 ]
Vancouver
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 9. 2019 ;[citado 2024 ago. 09 ]
Trabalho de evento-resumo
Synthesis and docking study for compounds analogs of LSD1 inhibitor (2019)
Lima, Elys Juliane Cardoso; Maltarollo, Vinícius Gonçalves ; Ganesan, Arasu; Emery, Flavio da Silva ; Wünsch, B; Trossini, Gustavo Henrique Goulart
Fonte: Abstracts. Nome do evento: Brazilian Symposium on Medicinal Chemistry - BrazMedChem. Unidades: FCFRP, FCF
Assuntos: NEOPLASIAS, COMPOSTOS HETEROCÍCLICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Elys Juliane Cardoso et al. Synthesis and docking study for compounds analogs of LSD1 inhibitor. 2019, Anais.. Campinas: Galoá, 2019. Disponível em: https://proceedings.science/brazmed-chem-2019/trabajos. Acesso em: 09 ago. 2024.
APA
Lima, E. J. C., Maltarollo, V. G., Ganesan, A., Emery, F. da S., Wünsch, B., & Trossini, G. H. G. (2019). Synthesis and docking study for compounds analogs of LSD1 inhibitor. In Abstracts. Campinas: Galoá. Recuperado de https://proceedings.science/brazmed-chem-2019/trabajos
NLM
Lima EJC, Maltarollo VG, Ganesan A, Emery F da S, Wünsch B, Trossini GHG. Synthesis and docking study for compounds analogs of LSD1 inhibitor [Internet]. Abstracts. 2019 ;[citado 2024 ago. 09 ] Available from: https://proceedings.science/brazmed-chem-2019/trabajos
Vancouver
Lima EJC, Maltarollo VG, Ganesan A, Emery F da S, Wünsch B, Trossini GHG. Synthesis and docking study for compounds analogs of LSD1 inhibitor [Internet]. Abstracts. 2019 ;[citado 2024 ago. 09 ] Available from: https://proceedings.science/brazmed-chem-2019/trabajos
Artigo de periodico
β-amino alcohols and their respective 2-phenyl-N-alkyl aziridines as potential DNA minor groove binders (2018)
Vaidergorn, Miguel M; Carneiro, Zumira A; Lopes, Carla D; Albuquerque, Sérgio de; Reis, Felipe C. C; Nikolaou, Sofia; Mello, Juliana F. R; Genesi, Giovani L; Trossini, Gustavo Henrique Goulart ; Ganesan, A; Emery, Flavio da Silva
Fonte: European Journal of Medicinal Chemistry. Unidades: FCFRP, FFCLRP, FCF
Assuntos: DNA, COMPOSTOS ORGÂNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VAIDERGORN, Miguel M et al. β-amino alcohols and their respective 2-phenyl-N-alkyl aziridines as potential DNA minor groove binders. European Journal of Medicinal Chemistry, v. 157, p. 657-664, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2018.07.055. Acesso em: 09 ago. 2024.
APA
Vaidergorn, M. M., Carneiro, Z. A., Lopes, C. D., Albuquerque, S. de, Reis, F. C. C., Nikolaou, S., et al. (2018). β-amino alcohols and their respective 2-phenyl-N-alkyl aziridines as potential DNA minor groove binders. European Journal of Medicinal Chemistry, 157, 657-664. doi:10.1016/j.ejmech.2018.07.055
NLM
Vaidergorn MM, Carneiro ZA, Lopes CD, Albuquerque S de, Reis FCC, Nikolaou S, Mello JFR, Genesi GL, Trossini GHG, Ganesan A, Emery F da S. β-amino alcohols and their respective 2-phenyl-N-alkyl aziridines as potential DNA minor groove binders [Internet]. European Journal of Medicinal Chemistry. 2018 ; 157 657-664.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1016/j.ejmech.2018.07.055
Vancouver
Vaidergorn MM, Carneiro ZA, Lopes CD, Albuquerque S de, Reis FCC, Nikolaou S, Mello JFR, Genesi GL, Trossini GHG, Ganesan A, Emery F da S. β-amino alcohols and their respective 2-phenyl-N-alkyl aziridines as potential DNA minor groove binders [Internet]. European Journal of Medicinal Chemistry. 2018 ; 157 657-664.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1016/j.ejmech.2018.07.055
Trabalho de evento-resumo
Virtual screening applied in hit identification as LSD1 inhibitors, a epigenetic target for cancer treatment (2017)
Lima, Elys Juliane Cardoso; Maltarollo, Vinícius Gonçalves; Ganesan, Arasu; Emery, Flavio da Silva; Trossini, Gustavo Henrique Goulart
Fonte: Proceedings. Nome do evento: World Chemistry Congress. Unidades: FCFRP, FCF
Assuntos: INIBIDORES DE ENZIMAS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Elys Juliane Cardoso et al. Virtual screening applied in hit identification as LSD1 inhibitors, a epigenetic target for cancer treatment. 2017, Anais.. Durham: International Union of Pure and Applied Chemistry (IUPAC), 2017. Disponível em: http://www.neopixdmi.com.br/@mci/iupac2017/. Acesso em: 09 ago. 2024.
APA
Lima, E. J. C., Maltarollo, V. G., Ganesan, A., Emery, F. da S., & Trossini, G. H. G. (2017). Virtual screening applied in hit identification as LSD1 inhibitors, a epigenetic target for cancer treatment. In Proceedings. Durham: International Union of Pure and Applied Chemistry (IUPAC). Recuperado de http://www.neopixdmi.com.br/@mci/iupac2017/
NLM
Lima EJC, Maltarollo VG, Ganesan A, Emery F da S, Trossini GHG. Virtual screening applied in hit identification as LSD1 inhibitors, a epigenetic target for cancer treatment [Internet]. Proceedings. 2017 ;[citado 2024 ago. 09 ] Available from: http://www.neopixdmi.com.br/@mci/iupac2017/
Vancouver
Lima EJC, Maltarollo VG, Ganesan A, Emery F da S, Trossini GHG. Virtual screening applied in hit identification as LSD1 inhibitors, a epigenetic target for cancer treatment [Internet]. Proceedings. 2017 ;[citado 2024 ago. 09 ] Available from: http://www.neopixdmi.com.br/@mci/iupac2017/
Trabalho de evento-resumo
Construction and validation of the 3D-structure of T. Cruzi sirtuin-2 by modeling threading (2016)
Ferreira, Glaucio Monteiro; Maltarollo, Vinícius Gonçalves; Emery, Flavio da Silva; Trossini, Gustavo Henrique Goulart
Fonte: Abstracts. Nome do evento: American Chemical Society National Meeting & Exposition. Unidades: FCFRP, FCF
Assuntos: TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Glaucio Monteiro et al. Construction and validation of the 3D-structure of T. Cruzi sirtuin-2 by modeling threading. 2016, Anais.. Washington: American Chemical Society (ACS), 2016. . Acesso em: 09 ago. 2024.
APA
Ferreira, G. M., Maltarollo, V. G., Emery, F. da S., & Trossini, G. H. G. (2016). Construction and validation of the 3D-structure of T. Cruzi sirtuin-2 by modeling threading. In Abstracts. Washington: American Chemical Society (ACS).
NLM
Ferreira GM, Maltarollo VG, Emery F da S, Trossini GHG. Construction and validation of the 3D-structure of T. Cruzi sirtuin-2 by modeling threading. Abstracts. 2016 ;[citado 2024 ago. 09 ]
Vancouver
Ferreira GM, Maltarollo VG, Emery F da S, Trossini GHG. Construction and validation of the 3D-structure of T. Cruzi sirtuin-2 by modeling threading. Abstracts. 2016 ;[citado 2024 ago. 09 ]
Artigo de periodico
Synthesis of two 'heteroaromatic rings of the future' for applications in medicinal chemistry (2016)
Silva-Júnior, P. E; Rezende, L. C. D; Gimenes, Julia Possamai; Maltarollo, Vinícius Gonçalves; Dale, James; Trossini, Gustavo Henrique Goulart ; Emery, Flavio da Silva; Ganesan, A
Fonte: RSC Advances. Unidades: FCF, FCFRP
Assuntos: COMPOSTOS HETEROCÍCLICOS, QUÍMICA FARMACÊUTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA-JÚNIOR, P. E et al. Synthesis of two 'heteroaromatic rings of the future' for applications in medicinal chemistry. RSC Advances, v. 6, n. 27, p. 22777-22780, 2016Tradução . . Disponível em: https://doi.org/10.1039/c6ra01099g. Acesso em: 09 ago. 2024.
APA
Silva-Júnior, P. E., Rezende, L. C. D., Gimenes, J. P., Maltarollo, V. G., Dale, J., Trossini, G. H. G., et al. (2016). Synthesis of two 'heteroaromatic rings of the future' for applications in medicinal chemistry. RSC Advances, 6( 27), 22777-22780. doi:10.1039/c6ra01099g
NLM
Silva-Júnior PE, Rezende LCD, Gimenes JP, Maltarollo VG, Dale J, Trossini GHG, Emery F da S, Ganesan A. Synthesis of two 'heteroaromatic rings of the future' for applications in medicinal chemistry [Internet]. RSC Advances. 2016 ; 6( 27): 22777-22780.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1039/c6ra01099g
Vancouver
Silva-Júnior PE, Rezende LCD, Gimenes JP, Maltarollo VG, Dale J, Trossini GHG, Emery F da S, Ganesan A. Synthesis of two 'heteroaromatic rings of the future' for applications in medicinal chemistry [Internet]. RSC Advances. 2016 ; 6( 27): 22777-22780.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1039/c6ra01099g
Artigo de periodico
Hologram quantitative structure–activity relationship and comparative molecular interaction field analysis of aminothiazole and thiazolesulfonamide as reversible LSD1 inhibitors (2015)
Maltarollo, Vinícius Gonçalves; Honório, Káthia Maria; Emery, Flavio da Silva; Ganesa, Arasu; Trossini, Gustavo Henrique Goulart
Fonte: Future Medicinal Chemistry. Unidades: EACH, FCFRP, FCF
Assuntos: INIBIDORES DE ENZIMAS, ANTINEOPLÁSICOS, HOLOGRAMAS, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTAROLLO, Vinícius Gonçalves et al. Hologram quantitative structure–activity relationship and comparative molecular interaction field analysis of aminothiazole and thiazolesulfonamide as reversible LSD1 inhibitors. Future Medicinal Chemistry, v. 7, n. 11, p. 1381-1394, 2015Tradução . . Disponível em: https://doi.org/10.4155/fmc.15.68. Acesso em: 09 ago. 2024.
APA
Maltarollo, V. G., Honório, K. M., Emery, F. da S., Ganesa, A., & Trossini, G. H. G. (2015). Hologram quantitative structure–activity relationship and comparative molecular interaction field analysis of aminothiazole and thiazolesulfonamide as reversible LSD1 inhibitors. Future Medicinal Chemistry, 7( 11), 1381-1394. doi:10.4155/fmc.15.68
NLM
Maltarollo VG, Honório KM, Emery F da S, Ganesa A, Trossini GHG. Hologram quantitative structure–activity relationship and comparative molecular interaction field analysis of aminothiazole and thiazolesulfonamide as reversible LSD1 inhibitors [Internet]. Future Medicinal Chemistry. 2015 ; 7( 11): 1381-1394.[citado 2024 ago. 09 ] Available from: https://doi.org/10.4155/fmc.15.68
Vancouver
Maltarollo VG, Honório KM, Emery F da S, Ganesa A, Trossini GHG. Hologram quantitative structure–activity relationship and comparative molecular interaction field analysis of aminothiazole and thiazolesulfonamide as reversible LSD1 inhibitors [Internet]. Future Medicinal Chemistry. 2015 ; 7( 11): 1381-1394.[citado 2024 ago. 09 ] Available from: https://doi.org/10.4155/fmc.15.68

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Editora

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada